acut
respiratori
distress
syndrom
ard
caus
infecti
insult
pneumonia
variou
pathogen
relat
noninfecti
event
clinic
histopatholog
characterist
similar
across
sever
affect
patient
suggest
common
mode
immun
reaction
may
involv
immunopathogenesi
ard
may
etiolog
substanc
affin
respiratori
cell
induc
lung
cell
injuri
case
ard
substanc
origin
pathogen
also
injur
host
cell
molecular
level
substanc
variou
size
biochem
characterist
classifi
protein
substanc
nonprotein
substanc
immun
cell
immun
protein
may
recogn
act
substanc
includ
pathogen
protein
peptid
depend
upon
size
biochem
properti
substanc
theori
known
proteinhomeostasissystem
hypothesi
sever
chronic
ard
depend
amount
etiolog
substanc
correspond
immun
reaction
durat
appear
specif
immun
cell
repertoir
specif
immun
cell
control
substanc
therefor
treatment
earli
system
immun
modul
corticosteroid
andor
intraven
immunoglobulin
soon
possibl
may
reduc
aberr
immun
respons
potenti
stage
ard
acut
respiratori
distress
syndrom
ard
sever
acut
lung
injuri
critic
syndrom
caus
heterogen
etiolog
character
acut
progress
respiratori
symptom
sign
bilater
diffus
infiltr
chest
imag
sever
hypoxemia
sever
ard
associ
poor
prognosi
higher
mortal
berlin
definit
diagnost
hypoxemia
defin
decreas
arteri
pao
fio
ratio
paramet
mmhg
mild
ard
mmhg
moder
ard
mmhg
sever
ard
lung
perform
critic
function
suppli
oxygen
everi
cell
bodi
consist
combin
structur
basic
architectur
termin
airway
term
termin
bronchiol
termin
structur
compos
sever
respiratori
cell
type
includ
respiratori
epitheli
cell
endotheli
cell
stromal
cell
alveolar
macrophag
well
organspecif
cell
commonli
occur
termin
structur
organ
therefor
pathogenesi
ard
simpli
describ
extens
acut
injuri
specif
kind
respiratori
cell
directli
variou
insult
includ
infecti
agent
andor
host
immun
respons
secondarili
ischem
insult
pulmonari
thromboembol
near
drown
infecti
factor
pneumonia
withwithout
sepsi
caus
varieti
pathogen
includ
pneumococci
influenza
variou
pathogen
caus
pneumonia
occasion
pneumonia
progress
ard
multipl
organ
failur
death
tabl
pathogen
caus
pneumonia
may
regard
caus
ard
immunopathogenesi
ard
may
pneumonia
thu
extent
area
lung
injuri
may
determin
clinic
phenotyp
lung
injuri
major
patient
infect
respiratori
pathogen
influenza
virus
mycoplasma
pneumonia
pneumonia
asymptomat
mild
symptom
proport
patient
manifest
symptom
system
ill
fever
fatigu
myalgia
cough
accord
find
previou
studi
among
patient
system
symptom
small
proport
pneumonia
among
pneumonia
patient
smaller
proport
patient
develop
progress
pneumonia
ard
although
risk
factor
infant
elderli
comorbid
diseas
immunodefici
state
associ
develop
ard
variou
respiratori
infect
includ
influenza
viru
infect
previous
healthi
patient
also
develop
ard
exampl
spanish
flu
influenza
viru
epidem
past
measl
disast
south
pacif
island
popul
age
impact
exampl
mortal
rate
high
paradox
mortal
rate
highest
healthiest
age
group
ie
year
age
typic
compris
individu
activ
immun
function
find
suggest
host
factor
ie
immun
reaction
insult
pathogen
infect
may
determin
phenotyp
sever
prognosi
diseas
term
ard
variou
noninfecti
etiolog
condit
blunt
chest
contus
multipl
injuri
aspir
gastric
content
inhal
burn
pancreat
near
drown
multipl
blood
transfus
report
tabl
although
pathogenesi
etiolog
agent
ard
condit
remain
unknown
etiolog
substanc
induc
inflamm
immun
cell
induc
lung
cell
injuri
patholog
find
pneumonia
ard
may
vari
accord
etiolog
agent
stage
diseas
howev
typic
patholog
advanc
ard
patient
anim
show
similar
find
includ
diffus
alveolar
damag
hyalin
membran
format
along
alveolar
wall
extens
immun
cell
infiltr
neutrophil
cell
lung
parenchyma
around
damag
alveoli
state
distribut
immun
cell
immun
protein
pneumonia
lesion
may
inform
etiolog
sever
lung
diseas
exampl
neutrophil
phagocyt
monocyt
may
predomin
cell
found
earlyphas
lesion
pneumococc
pneumonia
wherea
small
lymphocyt
predomin
immun
cell
earli
lesion
viral
mycoplasma
pneumonia
eosinophil
predomin
cell
eosinophil
pulmonari
diseas
addit
precipit
immunoglobulin
patholog
lesion
also
vari
accord
diseas
entiti
exampl
class
locat
precipit
immunoglobulin
igg
iga
igm
vari
accord
renal
diseas
entiti
thu
migrat
immun
cell
immun
protein
patholog
lesion
ard
thought
necess
immun
reaction
oppos
nonspecif
bystand
reaction
chemokin
stimul
local
lesion
believ
respiratori
pathogen
especi
small
pathogen
respiratori
virus
mycoplasma
induc
inflamm
patholog
lesion
spread
lower
respiratori
cell
along
respiratori
tract
howev
intact
virus
found
larg
proport
patient
fatal
outcom
experiment
anim
extens
patholog
lesion
ard
caus
pathogen
includ
pandem
influenza
virus
thu
pathogen
may
larg
act
direct
toxin
host
cell
molecular
biolog
level
vivo
characterist
sign
symptom
system
infecti
diseas
fever
onset
variou
tissu
injuri
may
initi
abrupt
releas
toxic
substanc
initi
infect
site
system
circul
nearli
infecti
diseas
includ
pneumonia
may
primari
infect
site
focu
pathogen
replic
toxic
substanc
produc
releas
nearbi
local
lesion
system
circul
extracellular
bacteri
infect
pneumococc
pneumonia
scarlet
fever
intracellular
bacteri
infect
typhoid
fever
legionella
intracellular
viral
infect
small
bacteri
infect
mycoplasma
pneumonia
may
initi
foci
replic
pathogen
bacteri
infect
includ
pneumococc
infect
extracellular
pathogen
focu
replic
site
may
produc
lot
substanc
substanc
includ
bacteria
fragment
bacteri
compon
polysaccharid
capsul
pamp
bacteri
exotoxin
pneumolysin
bacteriosin
materi
injur
cell
includ
heat
shock
protein
damp
protein
activ
immun
cell
proinflammatori
cytokin
proteolyt
enzym
small
pathogen
virus
mycoplasma
rickettsia
chlamydia
larger
pathogen
parasit
invad
host
establish
focu
contain
multipli
pathogen
substanc
fragment
pathogenorigin
materi
damag
cell
toxic
substanc
host
cell
well
bacteri
infect
multipl
pathogen
type
toxic
substanc
includ
virul
factor
may
depend
genom
size
pathogen
infecti
diseas
term
bacteremia
viremia
could
interpret
state
system
spread
pathogen
relat
substanc
accordingli
prognosi
ard
bacteri
sepsi
may
graver
comparison
condit
although
pathogen
detect
around
replic
site
upper
respiratori
tract
respiratori
diseas
includ
influenza
virus
corona
virus
mycoplasma
legionella
specif
igm
igg
antibodi
pathogen
detect
least
three
four
day
onset
fever
clinic
symptom
find
suggest
specif
antibodi
substanc
pathogen
produc
initi
replic
stage
incub
period
host
instead
system
immun
respons
pathogen
fragment
pathogen
may
begin
invas
substanc
system
circul
host
antibodi
format
pathogen
disappear
rapidli
local
lesion
system
spread
lesion
suggest
import
role
adapt
immun
respons
pathogen
remov
anim
depress
cell
function
loss
cell
function
nude
mice
show
milder
pneumonia
lesion
comparison
immunecompet
anim
mycoplasma
influenza
viru
infect
model
although
durat
pathogen
detect
lung
anim
compromis
cell
longer
find
suggest
lung
injuri
associ
cell
activ
rather
pathogen
clinic
cours
pneumonia
extrapulmonari
manifest
skin
rash
myositi
meningoencephalopathi
organ
involv
occasion
occur
pathogen
mycoplasma
exhibit
cytopath
effect
organ
cell
except
ciliat
respiratori
epitheli
cell
vitro
intact
pathogen
seen
pulmonari
extrapulmonari
lesion
whether
lower
respiratori
tract
cell
damag
directli
wide
varieti
small
pathogen
vivo
remain
unclear
also
unclear
whether
extrapulmonari
cell
appropri
receptor
varieti
virus
enter
target
cell
critic
organspecif
diseas
serious
damag
whole
organ
within
short
period
time
includ
ard
lung
exampl
critic
organspecif
diseas
fulmin
hepat
liver
acut
myocard
heart
rapidli
progress
glomerulonephr
kidney
acut
necrot
pancreat
pancrea
acut
encephalopathi
includ
rey
syndrom
brain
waterhousefriderichsen
syndrom
adren
gland
toxic
epidermolysi
skin
acut
hemorrhag
shock
syndrom
organspecif
diseas
associ
one
etiolog
agent
includ
variou
pathogen
gener
organspecif
diseas
may
similar
patholog
find
extens
termin
organ
cell
damag
massiv
immun
cell
infiltr
ard
also
direct
detect
intact
pathogen
difficult
extens
patholog
lesion
except
occasion
posit
result
polymeras
chain
reaction
import
note
pathogenderiv
substanc
also
host
cellderiv
substanc
caus
ard
acut
organspecif
diseas
sever
diseas
associ
host
cell
damag
damag
inflict
upon
cell
one
organ
affect
cell
organ
cell
origin
organ
exampl
sympathet
ophthalmia
occur
traumat
injuri
one
eyebal
inflamm
occur
within
ocular
tissu
eyebal
treat
promptli
corticosteroid
enucl
injur
eye
blind
occur
eye
rhabdomyolysi
acut
muscl
cell
injuri
caus
variou
factor
infect
influenza
measl
physic
injuri
drug
well
ard
rhabdomyolysi
caus
acut
kidney
injuri
dissemin
intravascular
coagul
dic
blood
heart
arrhythmia
complic
may
due
system
circul
extens
substanc
deriv
injur
muscl
cell
includ
myoglobin
potassium
toxic
materi
target
cell
accordingli
assumpt
may
explain
nonpathogeninduc
ard
occur
blunt
trauma
multipl
tissu
injuri
pancreat
sever
burn
caus
accept
product
activ
immun
cell
includ
proteolyt
protein
myeloperoxidas
proteinas
neutrophil
major
basic
protein
eosinophil
cation
protein
eosinophil
proinflammatori
cytokin
induc
inflamm
variou
tissu
includ
lung
tissu
ard
rapidli
progress
organspecif
diseas
substanc
deriv
initi
focu
may
affin
receptor
organspecif
cell
addit
toxic
substanc
could
produc
organspecif
cell
injur
initi
insult
case
sympathet
ophthalmia
immun
cell
may
activ
control
target
substanc
commun
across
immun
cell
may
need
process
excess
proinflammatori
cytokin
produc
may
also
associ
rapid
progress
certain
organ
specif
diseas
mechan
cytokin
imbal
induc
host
cell
injuri
howev
remain
elucid
summar
etiolog
substanc
induc
inflamm
patholog
lesion
ard
organspecif
diseas
immun
cell
immun
protein
lesion
may
role
recoveri
host
diseas
etiolog
substanc
control
immun
cell
immun
protein
role
immun
cell
immun
protein
theoret
may
patholog
lesion
ard
caus
variou
etiolog
immun
system
host
control
pathogen
invad
host
therebi
determin
prognosi
patient
infecti
diseas
includ
pneumonia
main
role
immunerepair
system
host
believ
prevent
tissu
cell
injuri
repair
tissu
cell
damag
infecti
insult
includ
variou
virul
factor
varieti
virul
factor
differ
infect
investig
viru
infect
influenza
corona
viru
infect
degre
affin
virus
lower
respiratori
tract
cell
import
factor
secretori
toxic
substanc
report
small
number
gene
product
gene
gene
associ
influenza
sever
acut
respiratori
syndrom
sar
pneumonia
pneumonia
report
cell
membran
compon
lipoprotein
secretori
communityacquir
respiratori
distress
syndrom
toxin
may
induc
respiratori
epitheli
cell
injuri
pneumococc
infect
structur
compon
bacteria
includ
capsul
polysaccharid
bacteri
dna
lipotecho
acid
pneumococc
surfac
protein
cholinebind
protein
well
secretori
protein
includ
pneumolysin
bacteriosin
propos
induc
lung
inflamm
lung
cell
injuri
divers
substanc
induc
lung
cell
injuri
howev
requir
research
studi
although
immun
system
mammal
classifi
innat
natur
adapt
specif
immun
system
type
immun
cell
found
nearli
patholog
lesion
infecti
diseas
rheumat
diseas
cancer
transplant
reject
regener
tissu
keloid
accordingli
believ
two
type
immun
system
cell
may
work
mutual
infecti
noninfecti
insult
function
type
immun
cell
immun
protein
may
ident
across
varieti
patholog
lesion
previous
mention
type
immun
system
cell
commun
major
histocompat
complex
mhc
proteinnetwork
cytokin
event
extern
intern
insult
abnorm
either
type
immun
cell
blockag
crosstalk
protein
immun
reaction
result
delay
remov
pathogen
respiratori
infect
includ
pneumococc
pneumonia
influenza
viru
infect
signific
question
remain
regard
control
substanc
substanc
control
etiolog
substanc
induc
lung
cell
injuri
may
variou
size
origin
extern
pathogen
andor
host
cell
previous
discuss
substanc
classifi
biochem
characterist
protein
substanc
nonprotein
substanc
addit
propos
innat
immun
system
cell
includ
natur
antibodi
may
control
nonprotein
substanc
adapt
immun
system
cell
may
control
protein
substanc
innat
immun
system
cell
neutrophil
phagocyt
monocyt
control
larger
substanc
whole
bacteria
virus
well
larg
piec
destruct
cell
apoptot
bodi
necrot
debri
phagocytosi
work
effect
togeth
product
immun
cell
antibodi
complement
small
nonprotein
substanc
pamp
viral
dna
rna
bind
produc
antipathogen
protein
interferon
interferonrel
protein
proinflammatori
cytokin
protein
type
immun
system
cell
may
commun
immunolog
event
protein
produc
innat
immun
system
cell
may
affect
function
adapt
immun
system
cell
includ
express
costimulatori
receptor
adapt
immun
cell
differenti
cell
subtyp
natur
antibodi
particular
part
innat
immun
system
may
also
control
nonprotein
substanc
polysaccharid
nonprotein
substanc
injur
host
cell
adapt
immun
system
cell
cell
b
cell
may
control
protein
substanc
use
cell
receptor
tcr
b
cell
receptor
bcr
gene
recombin
briefli
describ
process
b
cell
control
mediums
protein
via
product
antibodi
cell
control
small
peptid
induc
antibodi
via
potenti
cell
receptor
tcr
generel
immun
reaction
exampl
prr
innat
immun
cell
may
work
small
nonprotein
toxic
substanc
pathogen
pamp
bcr
tcr
adapt
immun
system
cell
work
protein
toxic
substanc
pathogen
receptorantigen
bind
signal
transduct
produc
new
protein
control
pathogen
antipathogen
protein
pathogenspecif
antibodi
clinic
cours
patholog
find
ard
tend
similar
regardless
underli
disord
immunopathogenesi
ard
explain
follow
substanc
toxic
kind
lung
cell
origin
infecti
focu
damag
host
cell
noninfecti
condit
subsequ
bind
receptor
target
respiratori
cell
affect
respiratori
cell
signal
produc
new
protein
commun
immun
cell
addit
process
may
damag
target
cell
releas
cell
content
includ
variouss
substanc
pp
pathogen
peptid
recruit
correspond
immun
cell
control
expos
substanc
earli
stage
ard
innat
immun
system
cell
neutrophil
nonspecif
cell
nonspecif
antibodi
b
cell
immun
protein
possibl
immun
peptid
may
compris
firstlin
effector
control
variouss
substanc
may
induc
inflamm
patholog
lesion
howev
nonspecif
cell
nonspecif
antibodi
effect
specif
effector
particular
task
appear
specif
immun
cell
cell
specif
antibodi
b
cell
etiolog
protein
substanc
includ
pp
pathogen
peptid
effect
control
inflamm
process
ceas
immun
cell
may
commun
cytokin
network
process
hyperact
immun
phenomena
extens
amount
substanc
imbal
cytokin
ie
cytokin
storm
may
respons
lung
injuri
host
immun
cell
clone
unabl
control
pp
substanc
injur
lung
cell
ard
may
progress
death
acut
stage
caus
chronic
inflammatori
respiratori
diseas
due
continu
activ
nonspecif
immun
cell
therefor
possibl
virul
pathogen
especi
viral
infect
may
lie
abil
pathogen
replic
subsequ
host
cell
injuri
follow
invas
rather
abil
pathogen
produc
toxin
summar
substanc
ard
rapidli
massiv
produc
within
short
period
time
pathogen
replic
foci
andor
damag
cell
bind
target
lung
cell
via
system
andor
local
circul
system
variou
kind
substanc
may
similar
mode
bind
signal
lung
tissu
cell
may
respons
recruit
activ
correspond
immun
cell
acut
lung
injuri
sever
pneumonia
ard
may
depend
amount
substanc
toxic
respiratori
cell
first
target
earli
treatment
ard
reduc
toxic
substanc
soon
possibl
earli
antimicrobi
therapi
provis
antibiot
antivir
pathogeninduc
pneumonia
critic
reduc
number
pathogen
pathogenorigin
substanc
therebi
induc
earli
recoveri
diseas
antibiot
treatment
recommend
soon
possibl
bacteri
infect
suspect
hand
use
antibiot
alway
success
patient
communityacquir
pneumonia
cap
patient
bacteri
pneumonia
experi
complic
lung
abscess
empyema
pulmonari
gangren
necrot
pneumonia
pneumonia
remain
one
common
caus
mortal
young
children
five
year
age
develop
world
throughout
antibiot
era
furthermor
earli
treatment
antibiot
young
children
suspect
pneumonia
diagnos
clinic
criteria
world
health
organ
shown
reduc
referr
rate
hospit
prevent
treatment
failur
suggest
patient
affect
nonbacteri
respiratori
pathogen
pneumonia
patient
cap
develop
countri
especi
elderli
patient
underli
diseas
experi
treatment
failur
high
mortal
despit
earli
applic
antimicrobi
pneumonia
patient
septic
condit
show
transient
deterior
clinic
symptom
follow
antibiot
treatment
may
caus
cytokin
storm
character
extens
immun
cell
activ
larg
amount
substanc
produc
process
bacteri
death
antibiot
treatment
may
induc
rapid
defervesc
patient
pneumonia
pneumonia
patient
show
progress
pneumonia
despit
earli
treatment
adequ
antibiot
necrot
pneumonia
uniqu
type
lobar
pneumonia
caus
pneumococci
pathogen
patient
necrot
pneumonia
show
protract
clinic
cours
prolong
fever
despit
treatment
adequ
dose
antibiot
clinic
cours
comput
tomographi
find
rel
similar
among
patient
affect
differ
pathogen
suggest
common
pathogenesi
diseas
ischem
lung
injuri
caus
blood
vessel
occlus
insult
bacteri
infect
similar
find
observ
respiratori
viru
infect
influenza
viru
infect
patient
receiv
earli
antivir
treatment
oseltamivir
may
show
rapid
defervesc
patient
without
earli
antivir
treatment
patient
howev
shown
rapidli
progress
ard
despit
earli
antivir
treatment
find
suggest
antimicrobi
may
limit
ard
patient
infectionrel
condit
abnorm
immun
reaction
host
infecti
insult
cytokin
storm
suggest
part
immunopathogenesi
ard
earli
manag
type
immun
disturb
may
critic
prevent
progress
diseas
excess
substanc
variou
insult
react
type
organspecif
tissu
cell
induc
correspond
excess
respons
immun
cell
may
respons
damag
organspecif
cell
manifest
similar
clinic
patholog
find
order
reduc
abnorm
immun
reaction
immun
modul
especi
corticosteroid
use
pneumonia
ard
although
numer
studi
includ
studi
regard
influenza
pneumonia
conduct
corticosteroid
effect
patient
sever
pneumonia
ard
result
remain
controversi
caus
controversi
howev
may
time
therapi
dose
initi
steroid
schedul
treatment
patient
select
differ
across
exist
studi
recent
wellrandom
casecontrol
studi
report
earli
corticosteroid
treatment
antibiot
within
h
admiss
help
reduc
treatment
failur
morbid
adult
patient
sever
cap
consid
immunopathogenesi
pneumonia
ard
suggest
articl
earlier
treatment
ie
intervent
soon
possibl
fact
stand
show
better
outcom
also
observ
earli
system
immun
modul
corticosteroid
andor
intraven
immunoglobulin
ivig
antibiot
antivir
may
halt
progress
pneumonia
induc
rapid
recoveri
pulmonari
lesion
patient
pneumonia
influenza
viru
infect
influenza
pandem
observ
extens
pneumon
consolid
develop
rapidli
within
h
fever
onset
resolv
dramat
within
h
corticosteroid
andor
ivig
treatment
find
suggest
critic
period
revers
patholog
state
induc
earli
immun
modul
acut
bronchiol
selflimit
lower
respiratori
tract
infect
infanc
caus
variou
respiratori
pathogen
includ
respiratori
syncyti
virus
rhinovirus
pneumonia
howev
sever
affect
patient
show
sever
respiratori
distress
complic
includ
respiratori
failur
mechan
ventil
subsequ
bronchiol
obliteran
also
effect
corticosteroid
treatment
patient
acut
bronchiol
remain
controversi
despit
great
deal
exist
studi
appli
treatment
modal
patient
sever
acut
bronchiol
well
sever
pneumonia
influenza
pneumonia
consist
earli
shortterm
highdos
rapid
taper
corticosteroid
sever
bronchiol
patient
respiratori
distress
need
oxygen
suppli
time
present
hospit
use
intraven
methylprednisolon
mgkgday
initi
dose
regardless
patient
age
causal
virus
past
decad
institut
experienc
patient
progress
state
need
intens
care
unit
icu
mechan
ventil
respiratori
complic
among
patient
unpublish
observ
lymphopenia
may
characterist
sever
pneumonia
patient
infect
respiratori
pathogen
includ
influenza
virus
corona
virus
measl
viru
pneumonia
sever
lymphopenia
correl
sever
lung
injuri
autopsi
find
sever
ard
patient
experiment
anim
infect
influenza
virus
show
lymphocyt
deplet
whole
lymphoid
tissu
find
togeth
lymphocyt
predomin
earli
lung
lesion
suggest
immun
cell
includ
cell
may
control
substanc
pathogen
andor
injur
host
cell
possibl
limit
numer
capac
host
immun
system
mobil
immun
cell
relentless
substanc
counter
extens
lung
cell
injuri
immunecompet
patient
patient
underli
diseas
malnutrit
immunedefici
state
may
limit
repertoir
immun
cell
furthermor
sever
pneumonia
ard
viral
infect
tend
induc
subsequ
bacteri
infect
patient
add
workload
immun
cell
howev
prolong
highdos
corticosteroid
therapi
immunesuppress
advanc
ard
patient
may
suppress
work
immun
cell
includ
specif
cell
b
cell
may
control
etiolog
substanc
therefor
earli
manag
condit
ard
potenti
may
crucial
stage
hyperimmun
reaction
possibl
perform
nonspecif
adapt
immun
cell
respiratori
insult
event
propos
patient
acut
onset
respiratori
distress
dyspnea
without
wheez
treat
soon
possibl
earli
adequ
dosag
system
immun
modul
corticosteroid
andor
ivig
rational
recommend
may
rational
behind
recommend
earli
antibiot
antivir
sinc
may
critic
stage
lung
cell
injuri
due
hyperimmun
reaction
host
corticosteroid
dose
could
taper
rapidli
normal
act
immun
cell
especi
specif
immun
cell
may
appear
within
sever
day
week
time
insult
corticosteroid
multipot
immunemodulatori
antiinflammatori
mode
action
almost
human
diseas
includ
infecti
diseas
allerg
diseas
malign
rheumat
diseas
although
entir
mode
action
corticosteroid
unknown
corticosteroid
may
act
hyperact
immun
cell
need
diseas
control
case
hyperact
howev
immun
cell
may
overproduc
immun
substanc
proinflammatori
cytokin
immun
cell
affect
corticosteroid
especi
nonspecif
immatur
cell
b
cell
eosinophil
may
rapidli
elimin
apoptosi
intraven
immunoglobulin
ivig
altern
immunemodul
indic
highdos
ivig
extend
immunemedi
diseas
includ
kawasaki
diseas
diseas
report
ivig
show
benefici
effect
pulmonari
lesion
influenza
pneumonia
pneumonia
pneumonia
precis
mechan
immunemodulatori
antiinflammatori
effect
ivig
immunemedi
diseas
also
unknown
ivig
may
act
hyperimmun
reaction
host
via
bind
receptor
immun
cell
etiolog
substanc
includ
pp
protein
involv
inflammatori
pathway
corticosteroid
ie
hydrocortison
ivig
ie
serum
igg
regard
hostorigin
immun
control
vivo
possibl
host
immun
system
produc
adequ
dose
within
short
durat
exposur
acut
extens
substanc
infecti
insult
thu
patient
ard
acut
whole
organspecif
diseas
lymphopenia
earli
system
immunemodul
treatment
occurr
diffus
organspecif
cell
injuri
may
critic
especi
previous
healthi
immunecompet
patient
possibl
earli
adequ
dose
immun
modul
mitig
rapid
diseas
progress
reduc
morbid
possibl
prevent
irrevers
total
organ
destruct
although
eventu
recoveri
ard
depend
immun
statu
patient
aspect
support
care
especi
lung
prevent
ventil
therapi
import
protect
lung
ventil
strategi
low
tidal
volum
limit
drive
pressur
strategi
current
accept
major
way
improv
mortal
ard
main
purpos
protect
ventil
minim
lung
cell
injuri
avoid
releas
inflammatori
mediat
mechan
injur
lung
cell
therapeut
modal
extracorpor
membran
oxygen
ecmo
nutrit
support
antiinflammatori
therapi
also
import
delic
period
immun
cell
combat
insult
ard
pneumonia
ard
occur
heterogen
condit
immunopathogenesi
ard
may
similar
differ
condit
present
studi
present
unifi
immunopathogenesi
ard
use
ph
hypothesi
hypothesi
provid
compel
reason
unifi
immunopathogenesi
ard
give
rational
earli
treatment
system
immun
modul
patient
begin
stage
ard
sever
chronic
ard
depend
amount
etiolog
substanc
includ
pp
pathogen
peptid
durat
appear
specif
immun
cell
repertoir
specif
immun
cell
control
substanc
host
therefor
earli
system
immunemodul
corticosteroid
andor
ivig
therapi
administ
soon
possibl
reduc
initi
aberr
immun
respons
elicit
nonspecif
immun
cell
treatment
polici
sever
pneumonia
earli
ard
describ
rational
earli
antibiot
antivir
therapi
insofar
critic
earli
stage
immunemedi
lung
injuri
revers
prompt
intervent
author
declar
conflict
interest
